NG Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 8, 2025, 7:42 pm

Quick Insight

NG Industries Ltd, operating in the hospitals and medical services sector, currently trades at ₹156 per share with a market capitalization of ₹52.1 crore and a P/E ratio of 6.73, indicating potential undervaluation. The company boasts a solid ROE of 20.7% and ROCE of 23.6%, reflecting efficient capital utilization. With a healthy OPM of 12.30% and a comfortable ICR of 223.70x, NG Industries shows strong operational and financial health. However, the company's relatively high debt level of ₹1.78 crore and a CCC of 56 days warrant monitoring for liquidity concerns. Overall, investors should consider NG Industries as a fundamentally sound investment opportunity with room for growth but should keep an eye on its debt levels and working capital management.

Competitors of NG Industries Ltd

All Competitor Stocks of NG Industries Ltd

Quarterly Result

Last Updated: May 31, 2025, 5:36 am

Below is a detailed analysis of the quarterly data for NG Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 4.47 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Dec 2024) to 4.47 Cr., marking an increase of 0.47 Cr..
• For Expenses, as of Mar 2025, the value is 3.92 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.59 Cr. (Dec 2024) to 3.92 Cr., marking an increase of 0.33 Cr..
• For Operating Profit, as of Mar 2025, the value is 0.55 Cr.. The value appears strong and on an upward trend. It has increased from 0.41 Cr. (Dec 2024) to 0.55 Cr., marking an increase of 0.14 Cr..
• For OPM %, as of Mar 2025, the value is 12.30%. The value appears strong and on an upward trend. It has increased from 10.25% (Dec 2024) to 12.30%, marking an increase of 2.05%.
• For Other Income, as of Mar 2025, the value is -3.18 Cr.. The value appears to be declining and may need further review. It has decreased from 7.67 Cr. (Dec 2024) to -3.18 Cr., marking a decrease of 10.85 Cr..
• For Interest, as of Mar 2025, the value is 0.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.01 Cr. (Dec 2024) to 0.02 Cr., marking an increase of 0.01 Cr..
• For Depreciation, as of Mar 2025, the value is 0.17 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.16 Cr. (Dec 2024) to 0.17 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Mar 2025, the value is -2.82 Cr.. The value appears to be declining and may need further review. It has decreased from 7.91 Cr. (Dec 2024) to -2.82 Cr., marking a decrease of 10.73 Cr..
• For Tax %, as of Mar 2025, the value is -13.83%. The value appears to be improving (decreasing) as expected. It has decreased from 15.17% (Dec 2024) to -13.83%, marking a decrease of 29.00%.
• For Net Profit, as of Mar 2025, the value is -2.43 Cr.. The value appears to be declining and may need further review. It has decreased from 6.71 Cr. (Dec 2024) to -2.43 Cr., marking a decrease of 9.14 Cr..
• For EPS in Rs, as of Mar 2025, the value is -7.25. The value appears to be declining and may need further review. It has decreased from 20.03 (Dec 2024) to -7.25, marking a decrease of 27.28.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 12:45 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:02 pm

Below is a detailed analysis of the balance sheet data for NG Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 3.35 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.35 Cr..
• For Reserves, as of Mar 2025, the value is 35.17 Cr.. The value appears strong and on an upward trend. It has increased from 32.79 Cr. (Mar 2024) to 35.17 Cr., marking an increase of 2.38 Cr..
• For Borrowings, as of Mar 2025, the value is 1.78 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.18 Cr. (Mar 2024) to 1.78 Cr., marking an increase of 0.60 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1.32 Cr.. The value appears to be improving (decreasing). It has decreased from 2.60 Cr. (Mar 2024) to 1.32 Cr., marking a decrease of 1.28 Cr..
• For Total Liabilities, as of Mar 2025, the value is 41.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 39.92 Cr. (Mar 2024) to 41.62 Cr., marking an increase of 1.70 Cr..
• For Fixed Assets, as of Mar 2025, the value is 5.64 Cr.. The value appears strong and on an upward trend. It has increased from 5.62 Cr. (Mar 2024) to 5.64 Cr., marking an increase of 0.02 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 31.94 Cr.. The value appears strong and on an upward trend. It has increased from 28.95 Cr. (Mar 2024) to 31.94 Cr., marking an increase of 2.99 Cr..
• For Other Assets, as of Mar 2025, the value is 4.04 Cr.. The value appears to be declining and may need further review. It has decreased from 5.35 Cr. (Mar 2024) to 4.04 Cr., marking a decrease of 1.31 Cr..
• For Total Assets, as of Mar 2025, the value is 41.62 Cr.. The value appears strong and on an upward trend. It has increased from 39.92 Cr. (Mar 2024) to 41.62 Cr., marking an increase of 1.70 Cr..

Notably, the Reserves (35.17 Cr.) exceed the Borrowings (1.78 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for NG Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 23.10. This value is within the healthy range. It has increased from 15.02 (Mar 24) to 23.10, marking an increase of 8.08.
• For Diluted EPS (Rs.), as of Mar 25, the value is 23.10. This value is within the healthy range. It has increased from 15.02 (Mar 24) to 23.10, marking an increase of 8.08.
• For Cash EPS (Rs.), as of Mar 25, the value is 24.93. This value is within the healthy range. It has increased from 16.80 (Mar 24) to 24.93, marking an increase of 8.13.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.96. It has increased from 107.85 (Mar 24) to 114.96, marking an increase of 7.11.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 114.96. It has increased from 107.85 (Mar 24) to 114.96, marking an increase of 7.11.
• For Dividend / Share (Rs.), as of Mar 25, the value is 3.50. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Mar 24) which recorded 3.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 49.39. It has decreased from 50.39 (Mar 24) to 49.39, marking a decrease of 1.00.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 29.24. This value is within the healthy range. It has increased from 19.30 (Mar 24) to 29.24, marking an increase of 9.94.
• For PBIT / Share (Rs.), as of Mar 25, the value is 27.41. This value is within the healthy range. It has increased from 17.52 (Mar 24) to 27.41, marking an increase of 9.89.
• For PBT / Share (Rs.), as of Mar 25, the value is 27.28. This value is within the healthy range. It has increased from 17.47 (Mar 24) to 27.28, marking an increase of 9.81.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 23.10. This value is within the healthy range. It has increased from 15.02 (Mar 24) to 23.10, marking an increase of 8.08.
• For PBDIT Margin (%), as of Mar 25, the value is 59.21. This value is within the healthy range. It has increased from 38.29 (Mar 24) to 59.21, marking an increase of 20.92.
• For PBIT Margin (%), as of Mar 25, the value is 55.51. This value exceeds the healthy maximum of 20. It has increased from 34.77 (Mar 24) to 55.51, marking an increase of 20.74.
• For PBT Margin (%), as of Mar 25, the value is 55.24. This value is within the healthy range. It has increased from 34.67 (Mar 24) to 55.24, marking an increase of 20.57.
• For Net Profit Margin (%), as of Mar 25, the value is 46.77. This value exceeds the healthy maximum of 10. It has increased from 29.81 (Mar 24) to 46.77, marking an increase of 16.96.
• For Return on Networth / Equity (%), as of Mar 25, the value is 20.09. This value is within the healthy range. It has increased from 13.93 (Mar 24) to 20.09, marking an increase of 6.16.
• For Return on Capital Employeed (%), as of Mar 25, the value is 23.44. This value is within the healthy range. It has increased from 15.37 (Mar 24) to 23.44, marking an increase of 8.07.
• For Return On Assets (%), as of Mar 25, the value is 18.59. This value is within the healthy range. It has increased from 12.60 (Mar 24) to 18.59, marking an increase of 5.99.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.04. This value is within the healthy range. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has decreased from 0.47 (Mar 24) to 0.40, marking a decrease of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 1.65. This value is within the healthy range. It has decreased from 2.88 (Mar 24) to 1.65, marking a decrease of 1.23.
• For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has decreased from 2.52 (Mar 24) to 1.35, marking a decrease of 1.17.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.80. This value is below the healthy minimum of 4. It has decreased from 6.79 (Mar 24) to 2.80, marking a decrease of 3.99.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 23.29 (Mar 24) to 0.00, marking a decrease of 23.29.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 20.83 (Mar 24) to 0.00, marking a decrease of 20.83.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 76.71 (Mar 24) to 0.00, marking a decrease of 76.71.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 79.17 (Mar 24) to 0.00, marking a decrease of 79.17.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 223.70. This value is within the healthy range. It has decreased from 403.73 (Mar 24) to 223.70, marking a decrease of 180.03.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 177.70. This value is within the healthy range. It has decreased from 315.31 (Mar 24) to 177.70, marking a decrease of 137.61.
• For Enterprise Value (Cr.), as of Mar 25, the value is 54.07. It has increased from 51.23 (Mar 24) to 54.07, marking an increase of 2.84.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.27. This value exceeds the healthy maximum of 3. It has increased from 3.03 (Mar 24) to 3.27, marking an increase of 0.24.
• For EV / EBITDA (X), as of Mar 25, the value is 5.52. This value is within the healthy range. It has decreased from 7.92 (Mar 24) to 5.52, marking a decrease of 2.40.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.30. This value exceeds the healthy maximum of 3. It has increased from 3.10 (Mar 24) to 3.30, marking an increase of 0.20.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 76.70 (Mar 24) to 0.00, marking a decrease of 76.70.
• For Price / BV (X), as of Mar 25, the value is 1.42. This value is within the healthy range. It has decreased from 1.45 (Mar 24) to 1.42, marking a decrease of 0.03.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.30. This value exceeds the healthy maximum of 3. It has increased from 3.10 (Mar 24) to 3.30, marking an increase of 0.20.
• For EarningsYield, as of Mar 25, the value is 0.14. This value is below the healthy minimum of 5. It has increased from 0.09 (Mar 24) to 0.14, marking an increase of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness